Skip to main content

Table 4 Device-oriented endpoint within 12 months

From: Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

 

Total

Lesion length < 20 mm

Lesion length ≥20 mm

P-Value

Number of lesions

417

274

143

 

Scaffold thrombosis, N (%)

 

acute

0 (0)

0 (0)

0 (0)

0.04

subacute

1 (0.2)

0 (0.0)

1 (0.7)

 

Late

1 (0.2)

0 (0.0)

1 (0.7)

 

TLR, N (%)

14 (3.4)

4 (1.5)

10 (7.0)

0.01

MI, N (%)

6 (1.4)

2 (0.7)

4 (2.8)

0.14

Number of patients

321

186

135

 

DoCE, N (%)

17 (5.3)

5 (2.7)

12 (8.9)

0.015

Cardiac mortality, N (%)

2 (0.6)

0 (0.0)

2 (1.5)

0.10

  1. TLR ischemia-driven target lesion revascularization, MI myocardial infarction, not clearly related to a non-target vessel, DoCE device-oriented endpoints